Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182–8.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607–20.
Article PubMed PubMed Central Google Scholar
Abu-Alainin W, Gana T, Liloglou T, Olayanju A, Barrera LN, Ferguson R, et al. UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. J Pathol. 2016;238:423–33.
Article CAS PubMed Google Scholar
Chen J, Song W, Du Y, Li Z, Xuan Z, Zhao L, et al. Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation. Biochem Biophys Res Commun. 2018;499:433–40.
Article CAS PubMed Google Scholar
Valero V 3rd, Saunders TJ, He J, Weiss MJ, Cameron JL, Dholakia A, et al. Reliable detection of somatic mutations in fine needle aspirates of pancreatic cancer with next-generation sequencing: implications for surgical management. Ann Surg. 2016;263:153–61.
Yoo NJ, Kim HR, Kim YR, An CH, Lee SH. Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology. 2012;60:943–52.
Schulze K, Imbeaud S, Letouze E, Alexandrov LB, Calderaro J, Rebouissou S, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47:505–11.
Article CAS PubMed PubMed Central Google Scholar
Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M, et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology. 2008;135:1358–68.68 e1-4.
Article CAS PubMed Google Scholar
Lee B, Yoon K, Lee S, Kang JM, Kim J, Shim SH, et al. Homozygous deletions at 3p22, 5p14, 6q15, and 9p21 result in aberrant expression of tumor suppressor genes in gastric cancer. Genes Chromosomes Cancer. 2015;54:142–55.
Article CAS PubMed Google Scholar
Hanada N, Takahata T, Zhou Q, Ye X, Sun R, Itoh J, et al. Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer. 2012;12:66.
Article CAS PubMed PubMed Central Google Scholar
Shitani M, Sasaki S, Akutsu N, Takagi H, Suzuki H, Nojima M, et al. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. Tumour Biol. 2012;33:1307–17.
Article CAS PubMed Google Scholar
Peng JM, Bera R, Chiou CY, Yu MC, Chen TC, Chen CW, et al. Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice. Hepatology. 2018;67:2226–43.
Article CAS PubMed Google Scholar
Choi ES, Lee H, Lee CH, Goh SH. Overexpression of KLHL23 protein from read-through transcription of PHOSPHO2-KLHL23 in gastric cancer increases cell proliferation. FEBS Open Bio. 2016;6:1155–64.
Article CAS PubMed PubMed Central Google Scholar
Sun Z, Ke X, Salzberg SL, Kim D, Antonescu V, Cheng Y, et al. The novel fusion transcript NR5A2-KLHL29FT is generated by an insertion at the KLHL29 locus. Cancer. 2017;123:1507–15.
Article CAS PubMed Google Scholar
Shi L, Zhang W, Zou F, Mei L, Wu G, Teng Y. KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma. BMC Cancer. 2016;16:815.
Article PubMed PubMed Central Google Scholar
Chen J, Yu Y, Ji T, Ma R, Chen M, Li G, et al. Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma. Cancer Med. 2016;5:2678–87.
Article CAS PubMed PubMed Central Google Scholar
Kong W, Gao M, Jin Y, Huang W, Huang Z, Xie Z. Prognostic model of patients with liver cancer based on tumor stem cell content and immune process. Aging (Albany NY). 2020;12:16555–78.
Huang W, Li G, Wang Z, Zhou L, Yin X, Yang T, et al. A ten-N(6)-methyladenosine (m(6)A)-modified gene signature based on a risk score system predicts patient prognosis in rectum adenocarcinoma. Front Oncol. 2020;10:567931.
Song Y, Yuan H, Wang J, Wu Y, Xiao Y, Mao S. KLHL22 regulates the EMT and proliferation in colorectal cancer cells in part via the Wnt/beta-Catenin signaling pathway. Cancer Manag Res. 2020;12:3981–93.
Article CAS PubMed PubMed Central Google Scholar
Cui Y, Yang J, Bai Y, Li Q, Yao Y, Liu C, et al. ENC1 facilitates colorectal carcinoma tumorigenesis and metastasis via JAK2/STAT5/AKT axis-mediated epithelial mesenchymal transition and stemness. Front Cell Dev Biol. 2021;9:616887.
Article PubMed PubMed Central Google Scholar
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–W102.
Article CAS PubMed PubMed Central Google Scholar
Chen HY, Hu JY, Chen TH, Lin YC, Liu X, Lin MY, et al. KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination. Oncogene. 2015;34:5141–51.
Article CAS PubMed Google Scholar
Nabeshima T, Hamada S, Taguchi K, Tanaka Y, Matsumoto R, Yamamoto M, et al. Keap1 deletion accelerates mutant K-ras/p53-driven cholangiocarcinoma. Am J Physiol Gastrointest Liver Physiol. 2020;318:G419–G27.
Article CAS PubMed Google Scholar
Liu JZ, Hu YL, Feng Y, Jiang Y, Guo YB, Liu YF, et al. BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer. J Exp Clin Cancer Res. 2020;39:123.
Article CAS PubMed PubMed Central Google Scholar
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63:173–84.
Article CAS PubMed Google Scholar
Qin JJ, Cheng XD, Zhang J, Zhang WD. Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review. Cell Commun Signal. 2019;17:121.
Article PubMed PubMed Central Google Scholar
Lee Y, Chou TF, Pittman SK, Keith AL, Razani B, Weihl CC. Keap1/Cullin3 modulates p62/SQSTM1 activity via UBA domain ubiquitination. Cell Rep. 2017;19:188–202.
Article CAS PubMed PubMed Central Google Scholar
Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa J, Ishimura R, et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell. 2013;51:618–31.
Article CAS PubMed Google Scholar
Shao C, Tu C, Cheng X, Xu Z, Wang X, Shen J, et al. Inflammatory and senescent phenotype of pancreatic stellate cells induced by Sqstm1 downregulation facilitates pancreatic cancer progression. Int J Biol Sci. 2019;15:1020–9.
Article CAS PubMed PubMed Central Google Scholar
Lee DF, Kuo HP, Liu M, Chou CK, Xia W, Du Y, et al. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Mol Cell. 2009;36:131–40.
Article CAS PubMed PubMed Central Google Scholar
Koliaraki V, Pasparakis M, Kollias G. IKKbeta in intestinal mesenchymal cells promotes initiation of colitis-associated cancer. J Exp Med. 2015;212:2235–51.
Article CAS PubMed PubMed Central Google Scholar
Sakamoto K, Hikiba Y, Nakagawa H, Hayakawa Y, Yanai A, Akanuma M, et al. Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression. Gastroenterology. 2010;139:226–38.e6.
Article CAS PubMed Google Scholar
Gu L, Zhu Y, Lin X, Lu B, Zhou X, Zhou F, et al. The IKKbeta-USP30-ACLY axis controls lipogenesis and tumorigenesis. Hepatology. 2021;73:160–74.
Article CAS PubMed Google Scholar
Wang C, Hu NH, Yu LY, Gong LH, Dai XY, Peng C, et al. 2,3,5,4’-Tetrahydroxystilbence-2-O-beta-D-glucoside attenuates hepatic steatosis via IKKbeta/NF-kappaB and Keap1-Nrf2 pathways in larval zebrafish. Biomed Pharmacother. 2020;127:110138.
Article CAS PubMed Google Scholar
Schumann M, Hofmann A, Krutzke SK, Hilger AC, Marsch F, Stienen D, et al. Array-based molecular karyotyping in fetuses with isolated brain malformations identifies disease-causing CNVs. J Neurodev Disord. 2016;8:11.
留言 (0)